#Business #WallStreet
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
WSJ.com: US Business
PAID
This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.